LD-2 disclosure · 1st Quarter - Report
ACER THERAPEUTICS
Income$20Kfee reported
Client
- Description
- therapies for serious rare and life-threatening diseases with critical unmet medical need
- Location
- Massachusetts · United States of America
Registrant
- Description
- Government Affairs Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issuePharmacy
COVID 19 therapeutics and Medical Countermeasures, Rare Disease and Re-purposed drugs; - FY22 Defense Appropriations for MCM Development
LobbyistsDEBORAH LYNN BURRELL
TargetedSENATE · HOUSE OF REPRESENTATIVES